(Q40251434)

18 September 2017

title

Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A225026

4 June 2022

1 reference

Bunn PA Jr

2

1 reference

18 September 2017

P. A. Radice

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A225026

4 June 2022

P. A. Bunn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A225026

4 June 2022

D. C. Ihde

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A225026

4 June 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=225026

4 June 2022

publication date

1 August 1979

1 reference

18 September 2017

published in

Cancer Treatment Reports

1 reference

18 September 2017

volume

63

1 reference

18 September 2017

issue

8

1 reference

18 September 2017

page(s)

1231-1239

1 reference

18 September 2017

Identifiers

1 reference